Upstate Active Clinical Trials

Study Title:

RTOG 1008 - A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

What is the purpose of the study?

This randomized phase II trial is studying radiation therapy with or without chemotherapy to see how well it works in treating patients with high-risk malignant salivary gland tumors that have been removed by surgery.

Upstate Institutional Review Board (IRB) Number:


Study/Protocol ID:

RTOG 1008

Study Phase:


Patient Age Group:


Principal Investigator:

Seung Shin Hahn, MD

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Christine S Hall
Phone: 315-464-7608

Return to Previous Page || Search Again